Contact
Please use this form to send email to PR contact of this press release:
Antares Pharma Enters Exclusive License Agreement With Ferring Pharmaceuticals for Nocdurna® in U.S.
TO:
Please use this form to send email to PR contact of this press release:
Antares Pharma Enters Exclusive License Agreement With Ferring Pharmaceuticals for Nocdurna® in U.S.
TO: